scholarly article | Q13442814 |
P2093 | author name string | Masanori Fukushima | |
Minoru Suzuki | |||
Akira Maruhashi | |||
Koji Ono | |||
Yoshinori Sakurai | |||
Yoshihiro Kimura | |||
Kenichi Yoshimura | |||
Shin-Ichiro Masunaga | |||
Yuko Kinashi | |||
Yasunori Ariyoshi | |||
Teruhito Aihara | |||
Shin-Ichi Haginomori | |||
Junichi Hiratsuka | |||
Miyuki Niimi | |||
Ituro Kato | |||
P2860 | cites work | Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients | Q33504332 |
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. | Q34163118 | ||
The radiation biology of boron neutron capture therapy | Q34491960 | ||
First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. | Q40322496 | ||
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease | Q41327924 | ||
IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. | Q44100708 | ||
Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer | Q44267907 | ||
Effectiveness of BNCT for recurrent head and neck malignancies | Q45016236 | ||
Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial | Q46427505 | ||
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma | Q46742361 | ||
The Radiation Biology of Boron Neutron Capture Therapy | Q54019294 | ||
Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation | Q68085124 | ||
Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study | Q74105486 | ||
Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors | Q76338473 | ||
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer | Q79757577 | ||
Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck | Q80975892 | ||
Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies | Q81416970 | ||
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911 | Q81464422 | ||
Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer | Q83132147 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 146-153 | |
P577 | publication date | 2013-08-16 | |
P1433 | published in | Journal of Radiation Research | Q2330802 |
P1476 | title | Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer | |
P478 | volume | 55 |
Q64085568 | 4-Borono-2-F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research |
Q38825221 | Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET. |
Q37630245 | Boron Neutron Capture Therapy - A Literature Review |
Q37348292 | Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study |
Q36184779 | Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy |
Q49255187 | Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection. |
Q38793345 | Effect of oxygen pressure during incubation with a (10)B-carrier on (10)B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of (10)B-carriers |
Q39003781 | Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma |
Q33881254 | Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer |
Q52729361 | Non-invasive estimation of 10 B-4-borono-L-phenylalanine-derived boron concentration in tumors by PET using 4-borono-2-18 F-fluoro-phenylalanine. |
Q58611070 | Proposal for determining absolute biological effectiveness of boron neutron capture therapy-the effect of 10B(n,α)7Li dose can be predicted from the nucleocytoplasmic ratio or the cell size |
Q47184614 | Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy |
Q35760848 | The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model. |
Q42210286 | The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams |
Q64113782 | Urinary Proteomics Profiles Are Useful for Detection of Cancer Biomarkers and Changes Induced by Therapeutic Procedures |
Q33875030 | Validation and Comparison of the Therapeutic Efficacy of Boron Neutron Capture Therapy Mediated By Boron-Rich Liposomes in Multiple Murine Tumor Models. |
Q48408462 | Whole-body dose evaluation with an adaptive treatment planning system for boron neutron capture therapy |